REG - Convatec Group PLC - Director/PDMR Shareholding

ConvaTecAnnouncement

Thu 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260312:nRSL4578Wa&default-theme=true

RNS Number : 4578W  Convatec Group PLC  12 March 2026

12 March 2026

Convatec Group Plc

("Convatec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transactions in relation to
Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary
shares of 10 pence each in the Company ("Shares").

1.    Grant of Performance Share Awards

On 11 March 2026, the following conditional awards were granted to each of
Jonny Mason, Chief Executive Officer and Fiona Ryder, Chief Financial Officer
under the Convatec Group Omnibus Incentive Plan 2025 ("LTIP") in the form of
Performance Share Awards ("PSA"). These PSA are due to vest on the third
anniversary of grant at nil cost, conditional on the following performance
conditions: organic revenue growth, three-year compound annualised growth in
adjusted Earnings per Share, and three-year Relative Total Shareholder Return
rank vs constituents of S&P Global Healthcare Equipment & Services
index; and are subject to a two-year post vesting holding period:

Jonny Mason:    1,776,206

Fiona Ryder:       567,413

2.    Grant of Deferred Bonus Awards

On the same date, the following conditional awards were granted to each of
Jonny Mason and Fiona Ryder under the LTIP in the form of Deferred Bonus
Awards ("DBA"). The DBA are due to vest on the third anniversary of grant at
nil cost and are not subject to performance conditions:

Jonny Mason:    165,419

Fiona Ryder:       19,028

3.    Grant of Restricted Share Awards

On the same date, the following conditional awards were granted to each of
Jonny Mason and Fiona Ryder under the LTIP in the form of Restricted Share
Awards ("RSA"). The RSA are due to vest on the third anniversary of grant at
nil cost and are not subject to performance conditions:

Jonny Mason:    417,931

Fiona Ryder:       170,224

The preceding three-day average share price, closing on 10 March 2026, of
£2.4167 was used in determining each of the awards made under the LTIP.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Jonny Mason
 2   Reason for the notification
 a)  Position/Status                                                 Chief Executive Officer and PDMR
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                            Convatec Group Plc
 b)  LEI                                                          213800LS272L4FIDOH92
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument

                                                                     Ordinary share of 10p each in Convatec Group Plc
     Identification code                                          GB00BD3VFW73
 b)  Nature of the transaction                                    a.    Grant of PSA under the LTIP, subject to performance conditions.

                                                                  b.    Grant of DBA under the LTIP, subject to a time-based vesting period
                                                                  of three years.

                                                                  c.     Grant of RSA under the LTIP, subject to a time-based vesting period
                                                                  of three years.

 c)  Price(s) and volume(s)                                                                    Price(s)                     Volume(s)
     a.                                                                                        £0                              1,776,206
     b.                                                                                           £0                           165,419
     c.                                                                                           £0                           417,931
 d)  Aggregated information

     - Aggregated volume                                          2,359,556

     - Price                                                      £0
 e)  Date of the transaction                                      2026-03-11
 f)  Place of the transaction                                     Outside a trading venue

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Fiona Ryder
 2   Reason for the notification
 a)  Position/Status                                                 Chief Financial Officer and PDMR
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Convatec Group Plc
 b)  LEI                                                          213800LS272L4FIDOH92
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument

                                                                  Ordinary share of 10p each in Convatec Group Plc
     Identification code                                          GB00BD3VFW73
 b)  Nature of the transaction                                    a.    Grant of PSA under the LTIP, subject to performance conditions.

                                                                  b.    Grant of DBA under the LTIP, subject to a time-based vesting period
                                                                  of three years.

                                                                  c.     Grant of RSA under the LTIP, subject to a time-based vesting period
                                                                  of three years.

 c)  Price(s) and volume(s)                                                                    Price(s)                       Volume(s)
     a.                                                                                          £0                            567,413
     b.                                                                                          £0                            19,028
     c.                                                                                         £0                             170,224
 d)  Aggregated information

     - Aggregated volume                                          756,665

     - Price                                                         £0
 e)  Date of the transaction                                      2026-03-11
 f)  Place of the transaction                                     Outside a trading venue

 

 

 

Enquiries

James Kerton Company Secretary
 

Email: cosec@convatec.com

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 2.2 Information disclosed under article 19 of the Market Abuse
Regulation

About Convatec

 

Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in Advanced
Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000
colleagues, we provide products and services in around 90 countries, united by
a promise to be forever caring. Our solutions provide a range of benefits,
from infection prevention, treatment for hard to heal wounds, at-risk skin and
ulcerated tissue to supporting debilitating conditions, improved patient
outcomes and reduced care costs. Convatec's revenues in 2025 were over $2
billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To
learn more please visit http://www.convatecgroup.com
(https://www.convatecgroup.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFEVVIIFLIR



            Copyright 2019 Regulatory News Service, all rights reserved